Bell Zhong joined Raymond James in 2020 as Managing Director focusing on biotechnology. Mr. Zhong previously worked for J.P. Morgan Securities, LLC, where he most recently held the title of executive director for health care investment banking covering biopharmaceutical companies. Previously he was an associate with Oppenheimer & Co., Inc. He brings over 15 years of experience in the financial services industry having begun his career at J.P. Morgan in 2005, and has spent more than a decade dedicated to biopharmaceuticals coverage. Mr. Zhong holds a Bachelor of Science degree in finance and accounting with minors in computer science and mathematics from the New York University Leonard N. Stern School of Business, where he graduated magna cum laude.